127 related articles for article (PubMed ID: 16739170)
1. Differentiation of mononuclear precursors into osteoclasts on the surface of Si-substituted hydroxyapatite.
Botelho CM; Brooks RA; Spence G; McFarlane I; Lopes MA; Best SM; Santos JD; Rushton N; Bonfield W
J Biomed Mater Res A; 2006 Sep; 78(4):709-20. PubMed ID: 16739170
[TBL] [Abstract][Full Text] [Related]
2. Human osteoblast response to silicon-substituted hydroxyapatite.
Botelho CM; Brooks RA; Best SM; Lopes MA; Santos JD; Rushton N; Bonfield W
J Biomed Mater Res A; 2006 Dec; 79(3):723-30. PubMed ID: 16871624
[TBL] [Abstract][Full Text] [Related]
3. Cellular compatibility of bone-like apatite containing silicon species.
Obata A; Kasuga T
J Biomed Mater Res A; 2008 Apr; 85(1):140-4. PubMed ID: 17688246
[TBL] [Abstract][Full Text] [Related]
4. The response of osteoblasts to nanocrystalline silicon-substituted hydroxyapatite thin films.
Thian ES; Huang J; Best SM; Barber ZH; Brooks RA; Rushton N; Bonfield W
Biomaterials; 2006 May; 27(13):2692-8. PubMed ID: 16423389
[TBL] [Abstract][Full Text] [Related]
5. Carbonate substituted hydroxyapatite: resorption by osteoclasts modifies the osteoblastic response.
Spence G; Patel N; Brooks R; Rushton N
J Biomed Mater Res A; 2009 Jul; 90(1):217-24. PubMed ID: 18496864
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of osteoblast and osteoclast precursors on pure and silicon-substituted synthesized hydroxyapatites.
Lehmann G; Cacciotti I; Palmero P; Montanaro L; Bianco A; Campagnolo L; Camaioni A
Biomed Mater; 2012 Oct; 7(5):055001. PubMed ID: 22781924
[TBL] [Abstract][Full Text] [Related]
7. Osteoclastogenesis on hydroxyapatite ceramics: the effect of carbonate substitution.
Spence G; Patel N; Brooks R; Bonfield W; Rushton N
J Biomed Mater Res A; 2010 Mar; 92(4):1292-300. PubMed ID: 19343778
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural comparison of hydroxyapatite and silicon-substituted hydroxyapatite for biomedical applications.
Porter AE; Best SM; Bonfield W
J Biomed Mater Res A; 2004 Jan; 68(1):133-41. PubMed ID: 14661258
[TBL] [Abstract][Full Text] [Related]
9. Suitability evaluation of sol-gel derived Si-substituted hydroxyapatite for dental and maxillofacial applications through in vitro osteoblasts response.
Balamurugan A; Rebelo AH; Lemos AF; Rocha JH; Ventura JM; Ferreira JM
Dent Mater; 2008 Oct; 24(10):1374-80. PubMed ID: 18417203
[TBL] [Abstract][Full Text] [Related]
10. In vitro osteoclast formation and resorption of silicon-substituted hydroxyapatite ceramics.
Friederichs RJ; Brooks RA; Ueda M; Best SM
J Biomed Mater Res A; 2015 Oct; 103(10):3312-22. PubMed ID: 25847383
[TBL] [Abstract][Full Text] [Related]
11. Biological response of human bone cells to zinc-modified Ca-Si-based ceramics.
Ramaswamy Y; Wu C; Zhou H; Zreiqat H
Acta Biomater; 2008 Sep; 4(5):1487-97. PubMed ID: 18501689
[TBL] [Abstract][Full Text] [Related]
12. Novel hydroxyapatite/chitosan bilayered scaffold for osteochondral tissue-engineering applications: Scaffold design and its performance when seeded with goat bone marrow stromal cells.
Oliveira JM; Rodrigues MT; Silva SS; Malafaya PB; Gomes ME; Viegas CA; Dias IR; Azevedo JT; Mano JF; Reis RL
Biomaterials; 2006 Dec; 27(36):6123-37. PubMed ID: 16945410
[TBL] [Abstract][Full Text] [Related]
13. Osteoclast differentiation from human blood precursors on biomimetic calcium-phosphate substrates.
Ciapetti G; Di Pompo G; Avnet S; Martini D; Diez-Escudero A; Montufar EB; Ginebra MP; Baldini N
Acta Biomater; 2017 Mar; 50():102-113. PubMed ID: 27940198
[TBL] [Abstract][Full Text] [Related]
14. The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro.
Boanini E; Torricelli P; Gazzano M; Fini M; Bigi A
Biomaterials; 2012 Jan; 33(2):722-30. PubMed ID: 22014461
[TBL] [Abstract][Full Text] [Related]
15. CD34 human hematopoietic progenitor cell line, MUTZ-3, differentiates into functional osteoclasts.
Ciraci E; Barisani D; Parafioriti A; Formisano G; Arancia G; Bottazzo G; Berardi AC
Exp Hematol; 2007 Jun; 35(6):967-77. PubMed ID: 17533051
[TBL] [Abstract][Full Text] [Related]
16. Effect of silicon level on rate, quality and progression of bone healing within silicate-substituted porous hydroxyapatite scaffolds.
Hing KA; Revell PA; Smith N; Buckland T
Biomaterials; 2006 Oct; 27(29):5014-26. PubMed ID: 16790272
[TBL] [Abstract][Full Text] [Related]
17. Signaling pathways of immobilized FGF-2 on silicon-substituted hydroxyapatite.
de la Concepción Matesanz M; Feito MJ; Ramírez-Santillán C; Lozano RM; Sánchez-Salcedo S; Arcos D; Vallet-Regí M; Portolés MT
Macromol Biosci; 2012 Apr; 12(4):446-53. PubMed ID: 22389324
[TBL] [Abstract][Full Text] [Related]
18. Importance of dynamic culture for evaluating osteoblast activity on dense silicon-substituted hydroxyapatite.
da Silva HM; Mateescu M; Damia C; Champion E; Soares G; Anselme K
Colloids Surf B Biointerfaces; 2010 Oct; 80(2):138-44. PubMed ID: 20579858
[TBL] [Abstract][Full Text] [Related]
19. Effect of sintered silicate-substituted hydroxyapatite on remodelling processes at the bone-implant interface.
Porter AE; Patel N; Skepper JN; Best SM; Bonfield W
Biomaterials; 2004 Jul; 25(16):3303-14. PubMed ID: 14980425
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyapatite surface roughness: complex modulation of the osteoclastogenesis of human precursor cells.
Costa-Rodrigues J; Fernandes A; Lopes MA; Fernandes MH
Acta Biomater; 2012 Mar; 8(3):1137-45. PubMed ID: 22178652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
